AIG
FENC icon

American International Group’s Fennec Pharmaceuticals FENC Stock Holding History

American International Group’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,944
Closed -$99.5K – 957
2024
Q1 		$99.5K Sell
8,944
-76
-0.8% -$763 ﹤0.01% 2515
2023
Q4 		$101K Sell
9,020
-37
-0.4% -$307 ﹤0.01% 2560
2023
Q3 		$68K Buy
9,057
+322
+4% +$2.62K ﹤0.01% 2723
2023
Q2 		$77.1K Buy
+8,735
New +$72.6K ﹤0.01% 2733
2021
Q2 		– Sell
-12,685
Closed -$79 – 3171
2021
Q1 		$79 Buy
12,685
+34
+0.3% +$256 ﹤0.01% 2820
2020
Q4 		$94 Sell
12,651
-134
-1% -$1.02K ﹤0.01% 2694
2020
Q3 		$78K Sell
12,785
-425
-3% -$3K ﹤0.01% 2659
2020
Q2 		$110K Buy
+13,210
New +$98.2K ﹤0.01% 2479
2019
Q2 		– Sell
-7,710
Closed -$37K – 3123
2019
Q1 		$37K Buy
7,710
+71
+0.9% +$467 ﹤0.01% 2938
2018
Q4 		$49K Sell
7,639
-58
-0.8% -$405 ﹤0.01% 2892
2018
Q3 		$63K Buy
7,697
+316
+4% +$2.93K ﹤0.01% 3012
2018
Q2 		$77K Buy
+7,381
New +$87.5K ﹤0.01% 2890

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SGL
Sonic GP LLC Honolulu, Hawaii $45.4M AUM 5.08% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return

American International Group's FENC Position: Q2 2024 in Review

American International Group sold out of Fennec Pharmaceuticals (FENC) in Q2 2024, closing a stake of 8,944 shares — an estimated $99.5K sold.

American International Group first reported a position in FENC in Q2 2018 and held it in 12 quarters. The position peaked at $110K in Q2 2020. 64 funds tracked by Wall St. Rank hold FENC as of Q2 2024.

  • American International Group reported no remaining Fennec Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 8,944 Fennec Pharmaceuticals shares in Q2 2024, an estimated $99.5K.
  • American International Group first reported a position in Fennec Pharmaceuticals in Q2 2018 and held it in 12 quarters.
  • American International Group's Fennec Pharmaceuticals position peaked at $110K in Q2 2020.
  • 64 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.